News
Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...
The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve ...
2d
MedPage Today on MSNFDA Scrutiny of Novavax COVID Shot Sparks Uncertainty About Other VaccinesThe unusual move at FDA comes shortly after the agency's longtime vaccine chief was forced out over disagreements with Makary ...
Kennedy won Senate confirmation to his job, in part, by promising not to change the nation’s vaccine schedule. Since taking ...
The Food and Drug Administration was set to release new guidance on COVID booster shots ahead of the fall season, but that's ...
The anticipated rollout of updated Covid vaccines this fall might be at risk after a change by Health and Human Services ...
Additional data required by the FDA are the latest evidence of what one analyst described as a “higher bar” for vaccines.
“Under Secretary Kennedy’s leadership, all new vaccines will undergo safety testing in placebo-controlled trials prior to ...
Moderna is deprioritizing its flu/COVID combination vaccine in younger adults amid a push to cut about $1.5 billion from its ...
The President Donald Trump administration's request for Novavax Inc. to conduct new clinical trials for its COVID-19 vaccine ...
Because the coronavirus continually mutates, manufacturers follow instructions from FDA to make one change each year to their recipe — which strain to target — just like flu vaccines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results